The incidence of menstrual regulation procedures and abortion in Bangladesh, 2014

International Perspectives on Sexual and Reproductive Health

Volumn 43, Issue 1, 2017, Pages 1-11

  Singh, Susheela ^a   Hossain, Altaf ^b   Maddow Zimet, Isaac ^a   Vlassoff, Michael ^a   Bhuiyan, Hadayeat Ullah ^b   Ingerick, Meghan ^a  

^a GUTTMACHER INSTITUTE   (United States)

^b Bangladesh Assoc Prev Septic A   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTION; CAPACITY BUILDING; DISEASE INCIDENCE; HEALTH SERVICES; HEALTH SURVEY; SERVICE PROVISION; TRAINING; WOMENS HEALTH;

BANGLADESH;

ABORTIVE AGENT; MISOPROSTOL;

ADOLESCENT; ADULT; AFTERCARE; BANGLADESH; BLEEDING; COMPLICATION; DRUG UTILIZATION; FAMILY PLANNING; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE SURVEY; HEALTH SERVICES RESEARCH; HOSPITAL; HUMAN; INCIDENCE; INDUCED ABORTION; MENSTRUAL CYCLE; MIDDLE AGED; PREGNANCY; PROCEDURES; SEPSIS; SPONTANEOUS ABORTION; STATISTICS AND NUMERICAL DATA; UNPLANNED PREGNANCY; UNWANTED PREGNANCY; YOUNG ADULT;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; AFTERCARE; BANGLADESH; DRUG UTILIZATION; FAMILY PLANNING SERVICES; FEMALE; HEALTH CARE SURVEYS; HEALTH PERSONNEL; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES RESEARCH; HEMORRHAGE; HOSPITALS; HUMANS; INCIDENCE; MENSTRUAL CYCLE; MIDDLE AGED; MISOPROSTOL; PREGNANCY; PREGNANCY, UNPLANNED; PREGNANCY, UNWANTED; SEPSIS; YOUNG ADULT;

EID: 85028662191     PISSN: 19440391     EISSN: 19440405     Source Type: Journal    
DOI: 10.1363/43e2417     Document Type: Article

References (42)

1. Singh S et al., The incidence of menstrual regulation procedures and abortion in Bangladesh, 2010, International Perspectives on Sexual and Reproductive Health, 2012, 38(3):122–132.
2. Vlassoff M et al., Menstrual Regulation and Postabortion Care in Bangladesh: Factors Associated with Access to and Quality of Services, New York: Guttmacher Institute, 2012, http://www.guttmacher.org/pubs/Bangladesh-MR.pdf.
3. Hossain A et al., Menstrual regulation, unsafe abortion, and maternal health in Bangladesh, In Brief, New York: Guttmacher Institute, 2012, No. 3.
4. Rahman M, DaVanzo J and Razzaque A, Pregnancy termination in Matlab, Bangladesh: maternal mortality risks associated with menstrual regulation and abortion, International Perspectives on Sexual and Reproductive Health, 2014, 40(3):108–118.
5. National Institute of Population Research and Training (NIPORT) et al., Bangladesh Maternal Health Services and Mortality Survey 2001, Dhaka, Bangladesh: NIPORT; and Calverton, MD, USA: ORC Macro, 2003.
6. NIPORT, Bangladesh Maternal Mortality and Health Care Survey 2010, Summary of Key Findings and Implications, Dhaka, Bangladesh: NIPORT, 2011.
7. Memo No. DGFP/MCH-S/NTC-4/138/95 (Part-05)/34: Agenda -4, Directorate General of Family Planning, 2014.
8. Alam A et al., Acceptability and feasibility of mifepristonemisoprostol misoprostol for menstrual regulation in Bangladesh, International Perspectives on Sexual and Reproductive Health, 2013, 39(2):79–87.
9. Oliveras E et al., Situation Analysis of Unsafe Abortion and Menstrual Regulation in Bangladesh, Dhaka, Bangladesh: International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B), 2008.
10. Mridha MK, Anwar I and Koblinsky M, Public-sector maternal health programmes and services for rural Bangladesh, Journal of Health, Population, and Nutrition, 2009, 27(2):124–138.
11. National Institute of Population Research and Training (NIPORT), Mitra and Associates, and ICF International. 2016. Bangladesh Demographic and Health Survey, 2014. Dhaka, Bangladesh, and Rockville, MD, USA: NIPORT, Mitra and Associates, and ICF International, 2016
12. Khan R et al., Menstrual Regulation: A Decision Tainted with Stigma, Pain and Suffering—An Anthropological Study, Dhaka, Bangladesh: Embassy of the Kingdom of the Netherlands (EKN), Marie Stopes Bangladesh, and icddr, b, 2016.
13. Hena IA et al., Introducing Medical MR in Bangladesh: MRM Final Report, Dhaka, Bangladesh: Population Council, 2013.
14. Hashemi A, Rashid S and Rashid M, Where do women go and why? Understanding the barriers to safe MR services in Bangladesh, unpublished report, Dhaka, Bangladesh: James P. Grant School of Public Health, BRAC University, 2012.
15. Banu N and Akhter QS, An observational study on use of misoprostol in termination of unintended pregnancy in a rural setting, Journal of Dhaka Medical College, 2010, 19(2):109–114.
16. Huda FA et al., Availability and provision of misoprostol and other medicines for menstrual regulation among pharmacies in Bangladesh via mystery client survey, International Journal of Gynaecology & Obstetrics, 2014, 124(2):164–168.
17. World Health Organization (WHO), Safe Abortion: Technical and Policy Guidance for Health Systems, second ed., Geneva: WHO, 2012.
18. Malik R et al., A prospective randomized, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy, Open Journal of Obstetrics and Gynecology, 2012, 2:81–84.
19. NIPORT, Mitra and Associates and Macro International, Bangladesh Demographic and Health Survey, 1993–1994, Dhaka, Bangladesh: NIPORT and Mitra and Associates; and Calverton, MD, USA: Macro International, 1994.
20. NIPORT, Mitra and Associates and ICF International, Bangladesh Demographic and Health Survey 2014 Key Indicators, Dhaka, Bangladesh: NIPORT and Mitra and Associates; and Rockville, MD, USA: ICF International, 2015.
21. Penal Code, 1860, as adopted by the Bangladesh Laws Revision and Declaration Act of 1973.
22. Singh S, Remez L and Tartaglione A, Methodologies for Estimating Abortion Incidence and Abortion-Related Morbidity: A Review, New York: Guttmacher Institute; and Paris: International Union for the Scientific Study of Population, 2010.
23. Sathar Z et al., Induced abortions and unintended pregnancies in Pakistan, Studies in Family Planning, 2014, 45(4):471–491.
24. Mohamed SF et al., The estimated incidence of induced abortion in Kenya: a cross-sectional study, BMC Pregnancy and Childbirth, 2015, 15:185.
25. Sedgh G et al., Estimates of the incidence of induced abortion and consequences of unsafe abortion in Senegal, International Perspectives on Sexual and Reproductive Health, 2015, 41(1):11–19.
26. Singh S, Prada E and Kestler E, Induced abortion andunintended pregnancy in Guatemala, International Family Planning Perspectives, 2006, 32(3):136–145.
27. Bongaarts J and Potter RE, Fertility, Biology, and Behavior: An Analysis of the Proximate Determinants, New York: Academic Press, 1983.
28. Harlap S, Shiono PH and Ramcharan S, A life table of spontaneous abortions and the effects of age, parity, and other variables, in: Porter IH and Hook EB, eds., Human Embryonic and Fetal Death, New York: Academic Press, 1980, pp. 145–158.
29. Bangladesh Bureau of Statistics, Bangladesh Population and Housing Census, 2001: Socio-Economic and Demographic Report, Dhaka, Bangladesh: Bangladesh Bureau of Statistics, 2001.
30. Bangladesh Bureau of Statistics, Bangladesh Population and Housing Census, 2011: Socio-Economic and Demographic Report, National Series, Volume 4, Dhaka, Bangladesh: Bangladesh Bureau of Statistics, 2012.
31. Chowdhury SNM and Moni D, A situation analysis of the menstrual regulation program in Bangladesh, Reproductive Health Matters, 2004, 12(24, Suppl.):95–104.
32. Huda F et al., Strengthening Health System Capacity to Monitor and Evaluate Programs Targeted at Reducing Abortion-Related Maternal Mortality, Final Report of the Safe Menstrual Regulation Care (SMRC) Project, January–December 2009, Dhaka, Bangladesh: ICDDR, B, 2010.
33. NIPORT, Mitra and Associates and ICF International, Bangladesh Demographic and Health Survey 2014, Dhaka, Bangladesh: NIPORT and Mitra and Associates; and Rockville, MD, USA: ICF International, 2016.
34. Directorate General of Family Planning, Bangladesh National Menstrual Regulation Service Guidelines, 2014, Dhaka, Bangladesh: Directorate General of Family Planning, Kingdom of the Netherlands, World Health Organization Country Office for Bangladesh, 2014.
35. Directorate General of Family Planning, Proceedings of the 62nd Meeting of the National Technical Committee (NTC) helssd on June 30, 2014. Dhaka, Bangladesh: Directorate General of Family Planning, 2014.
36. Briozzo L et al., A risk reduction strategy to prevent maternal deaths associated with unsafe abortion, International Journal of Gynecology and Obstetrics, 2006, 95(2):221–226.
37. Coeytaux F et al., Facilitating women’s access to misoprostol through community-based advocacy in Kenya and Tanzania, International Journal of Gynecology and Obstetrics, 2014, 125(1):53–55.
38. Erdman J, Access to information on safe abortion: a harm reduction and human rights approach, Harvard Journal of Law & Gender, 2011, 34:413–462.
39. Sundaram A et al., Documenting the individual- and household-level cost of unsafe abortion in Uganda, International Perspectives on Sexual and Reproductive Health, 2013, 39(4):174–184.
40. Singh S and Maddow-Zimet I, Facility-based treatment for medical complications resulting from unsafe pregnancy termination in the developing world, 2012: a review of evidence from 26 countries, BJOG, 2015, doi: 10.1111/1471-0528.13552.
41. Kumar A, Hessini L and Mitchell EM, Conceptualizing abortion stigma, Culture, Health & Sexuality, 2009, 11(6):625–639.
42. Sedgh G, Singh S and Hussain R, Intended and unintended pregnancies worldwide in 2012 and recent trends, Studies ins Family Planning, 2014, 45(3):301–314.